FDA and FTC Tell Monsanto to Quit Bellyaching (Part 2)

Here's the headline I put on the blog entry I just posted about the U.S. Food and Drug Administration's and Federal Trade Commission's responses to complaints from Monsanto that U.S. milk producers are "misleading" the citizenry about the Creve Coeur-based chemical company's product Posilac, a.k.a. rBST, a.k.a. recombinant bovine somatotropin, a.k.a. bovine growth hormone:

rwqp.rutgers.edu
FDA and FTC Tell Monsanto to Quit Bellyaching

Now here's the headline from the Business page of yesterday's St. Louis Post-Dispatch, atop a story by Rachel Melcer that covers the exact-same topic:

FTC takes websites to task on claims

Back in April, I wrote a pair of posts, one detailing Monsanto's complaints to the FDA and FTC, the other contrasting Melcer's story for the P-D with stories published by other news outlets.

Well, here we go again.

I'm not going to go over all the old ground. Let me just point you to the only other story about the denouement that's appeared so far, written by Associated Press writer Sam Hananel. That story was published in various newspapers around the nation under this headline:

FTC says milk ads on synthetic hormones not misleading

'Nuff said.

-Tom Finkel

My Voice Nation Help

Now Trending

From the Vault

 

Loading...